Letter by Altman and Gonzalez Regarding Article, “Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study” | Zendy

Raúl Altman | Zendy; Claudio González | Zendy

Open Access

Letter by Altman and Gonzalez Regarding Article, “Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study”

Author(s) -

Raúl Altman,

Claudio González

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.051128

Subject(s) - medicine , myocardial infarction , prostacyclin , thromboxane , cardiology , nonsteroidal , cohort , cyclooxygenase , platelet , biochemistry , chemistry , enzyme

To the Editor:We read with great interest the article by Schjerning Olsen et al1 reporting the recurrence of myocardial infarction after the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with established cardiovascular disease. Although the presented data are not new,2,3 they are of relevance for clinicians working in the real world. The mechanism underlying the prothrombotic effect of NSAIDs remains poorly understood, but it …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research